Literature DB >> 24379919

Classification of diabetic retinopathy and diabetic macular edema.

Lihteh Wu1, Priscilla Fernandez-Loaiza1, Johanna Sauma1, Erick Hernandez-Bogantes1, Marissé Masis1.   

Abstract

The global incidence and prevalence of diabetes mellitus (DM) have reached epidemic proportions. Estimates indicate that more than 360 million people will be affected by DM by 2030. All of these individuals will be at risk of developing diabetic retinopathy (DR). It is extremely important to categorize, classify and stage the severity of DR in order to establish adequate therapy. With proper management more than 90% of cases of visual loss can be prevented. The purpose of the current paper is to review the classification of DR with a special emphasis on the International Clinical Disease Severity Scale for DR. This new classification is simple to use, easy to remember and based on scientific evidence. It does not require specialized examinations such as optical coherence tomography or fluorescein angiography. It is based on clinical examination and applying the Early Treatment of Diabetic Retinopathy Study 4:2:1 rule.

Entities:  

Keywords:  Diabetic macular edema; Diabetic macular edema classification; Diabetic retinopathy; Diabetic retinopathy classification; International clinical disease severity scale

Year:  2013        PMID: 24379919      PMCID: PMC3874488          DOI: 10.4239/wjd.v4.i6.290

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  27 in total

1.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

Review 2.  Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.

Authors:  Gianni Virgili; Francesca Menchini; Vittoria Murro; Emanuela Peluso; Francesca Rosa; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

3.  Optical coherence tomographic patterns of diabetic macular edema.

Authors:  Brian Y Kim; Scott D Smith; Peter K Kaiser
Journal:  Am J Ophthalmol       Date:  2006-09       Impact factor: 5.258

4.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

5.  Diabetic macular edema. A review.

Authors:  G H Bresnick
Journal:  Ophthalmology       Date:  1986-07       Impact factor: 12.079

Review 6.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

7.  Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy.

Authors: 
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-07       Impact factor: 4.799

8.  Knowledge of diabetic retinopathy before and 18 years after the Airlie House Symposium on Treatment of Diabetic Retinopathy.

Authors:  M F Goldberg; L M Jampol
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

9.  Cost-effectiveness of detecting and treating diabetic retinopathy.

Authors:  J C Javitt; L P Aiello
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

10.  Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

Authors:  J C Javitt; L P Aiello; Y Chiang; F L Ferris; J K Canner; S Greenfield
Journal:  Diabetes Care       Date:  1994-08       Impact factor: 19.112

View more
  77 in total

1.  Treatment decisions in diabetic macular edema based on optical coherence tomography retinal thickness map: LET classification.

Authors:  Rosa Dolz-Marco; Rodrigo Abreu-González; Marta Alonso-Plasencia; Roberto Gallego-Pinazo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-09       Impact factor: 3.117

2.  Automatic differentiation of color fundus images containing drusen or exudates using a contextual spatial pyramid approach.

Authors:  Mark J J P van Grinsven; Thomas Theelen; Leonard Witkamp; Job van der Heijden; Johannes P H van de Ven; Carel B Hoyng; Bram van Ginneken; Clara I Sánchez
Journal:  Biomed Opt Express       Date:  2016-02-02       Impact factor: 3.732

3.  Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes.

Authors:  Jianxia Hu; Yangang Wang; Huimin Gong; Chundong Yu; Caihong Guo; Fang Wang; Shengli Yan; Hongmei Xu
Journal:  Exp Ther Med       Date:  2016-07-26       Impact factor: 2.447

4.  Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema.

Authors:  Marc Figueras-Roca; Jessica Matas; Víctor Llorens; Anna Sala-Puigdollers; Manuel Navarro; Javier Zarranz-Ventura; Alfredo Adán; Blanca Molins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-12       Impact factor: 3.117

Review 5.  Optical coherence tomography angiography (OCTA) flow speed mapping technology for retinal diseases.

Authors:  Malvika Arya; Ramy Rashad; Osama Sorour; Eric M Moult; James G Fujimoto; Nadia K Waheed
Journal:  Expert Rev Med Devices       Date:  2018-11-22       Impact factor: 3.166

6.  Association of insulin treatment versus oral hypoglycaemic agents with diabetic retinopathy and its severity in type 2 diabetes patients in Cameroon, sub-Saharan Africa.

Authors:  Ahmadou M Jingi; Jean Jacques N Noubiap; Mickael Essouma; Jean Joel R Bigna; Jobert Richie N Nansseu; Augustin Ellong; Côme Ebana Mvogo
Journal:  Ann Transl Med       Date:  2016-10

Review 7.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

8.  Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy.

Authors:  V S Reddy; P Agrawal; S Sethi; N Gupta; R Garg; H Madaan; V Kumar
Journal:  Eye (Lond)       Date:  2015-09-18       Impact factor: 3.775

Review 9.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

10.  Near reading speed changes after panretinal photocoagulation in diabetic retinopathy patients: a prospective study using an iPad application for the measurement of reading speed.

Authors:  Ji Soo Kim; Jin Young Kim; Kyung Tae Kim; Ju Byung Chae; Jae Hyung Kim; Dong Yoon Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.